Beam Therapeutics Inc. (BEAM) Social Stream



Beam Therapeutics Inc. (BEAM): $23.17

0.86 (-3.58%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add BEAM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#225 of 348

in industry

BEAM THERAPEUTICS INC (BEAM) Price Targets From Analysts

Use the tables below to see what analysts covering BEAM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 10 $150 $85 $124.333 $27.22 356.77%
2021-12-22 11 $150 $85 $121.555 $27.22 346.57%
2022-01-05 11 $150 $85 $122.4 $27.22 349.67%
2022-01-10 11 $159 $85 $124.5 $27.22 357.38%
2022-02-01 10 $159 $85 $124.5 $27.22 357.38%
2022-02-28 10 $159 $85 $126.25 $27.22 363.81%
2022-03-01 9 $154 $85 $124.625 $27.22 357.84%
2022-05-09 8 $154 $110 $130.285 $27.22 378.64%
2022-05-10 8 $154 $75 $114.142 $27.22 319.33%
2022-05-11 8 $130 $75 $110 $27.22 304.11%
2022-06-08 8 $130 $75 $103.142 $27.22 278.92%
2022-06-17 9 $130 $41 $95.375 $27.22 250.39%
2022-07-18 9 $130 $61 $97.875 $27.22 259.57%
2022-08-10 10 $130 $60 $92.666 $27.22 240.43%
2022-09-17 10 $130 $60 $90.125 $27.22 231.1%
2022-11-07 10 $130 $60 $89.222 $27.22 227.78%
2022-11-08 10 $130 $60 $84.666 $27.22 211.04%
2022-12-13 11 $130 $60 $82.4 $27.22 202.72%
2022-12-20 11 $130 $60 $82.9 $27.22 204.56%
2023-01-06 10 $103 $60 $77.222 $27.22 183.7%
2023-01-26 10 $103 $60 $76.777 $27.22 182.06%
2023-02-01 11 $103 $60 $75.3 $27.22 176.63%
2023-02-08 11 $103 $60 $74.3 $27.22 172.96%
2023-03-01 12 $103 $60 $74.1 $27.22 172.23%
2023-03-02 12 $105 $60 $74.727 $27.22 174.53%
2023-04-11 13 $105 $37 $71.583 $27.22 162.98%
2023-05-10 14 $105 $37 $71.416 $27.22 162.37%
2023-05-11 14 $105 $37 $69 $27.22 153.49%
2023-05-15 14 $105 $37 $68.615 $27.22 152.08%
2023-06-06 14 $105 $37 $68.461 $27.22 151.51%
2023-08-08 14 $105 $37 $67 $27.22 146.14%
2023-08-09 14 $105 $35 $65.615 $27.22 141.05%
2023-08-14 14 $105 $35 $65.307 $27.22 139.92%
2023-09-07 14 $105 $35 $63.23 $27.22 132.29%
2023-10-17 14 $105 $32 $61.384 $27.22 125.51%
2023-10-19 14 $105 $32 $60.615 $27.22 122.69%
2023-10-21 14 $105 $20 $54 $27.22 98.38%
2023-10-31 14 $95 $20 $53.333 $27.22 95.93%
2023-11-08 14 $95 $19 $53.25 $27.22 95.63%
2023-11-14 14 $95 $19 $51.833 $27.22 90.42%
2023-12-08 15 $95 $19 $51.615 $27.22 89.62%
2023-12-15 15 $95 $19 $50.153 $27.22 84.25%

The Trend in the Analyst Price Target


BEAM's average price target has moved up $18.4 over the prior 46 months.

Over the past 49 weeks, BEAM's average upside potential has been 122.15%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-06 11 103 60 74.300 47.91 55.08%
2023-03-02 13 105 60 74.727 38.81 92.55%
2023-05-15 14 105 37 68.461 35.99 90.22%
2023-06-06 14 105 37 67.000 34.33 95.16%
2023-10-19 14 105 32 60.615 18.36 230.15%

BEAM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.07 7 0 8 0 0 15

The Trend in the Broker Recommendations


BEAM's average broker recommendation rating worsened by 0.5 over the prior 31 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BEAM as an investment opportunity.

  • BEAM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 4888.08% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BEAM THERAPEUTICS INC's average analyst price target is greater than 4549.88% of them.
  • In the context of stocks in the mid market cap category, BEAM THERAPEUTICS INC's number of analysts covering the stock is higher than 4422.06% of them.
  • BEAM has a lower variance in analysts' estimates than -4229.56% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, PLX, EDIT, and FATE are the three stocks most similar to BEAM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is BEAM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!